National Cancer Centre Singapore – NCCS shared on LinkedIn:
“Proud of team NCCS for representing Singapore on the global stage at ESMO 2026 in Madrid, Spain!
Our researchers and clinicians are bringing their best to this year’s ESMO Annual Meeting, sharing cutting-edge findings and insights that are shaping the future of cancer care.
A huge congratulations to all our presenters! Your work reflects the dedication and excellence that drives everything we do at National Cancer Centre Singapore.”
You can read more about ESMO 2026:
JSKN033 at ESMO 2026: Shows 52.9% Response Rate in Pretreated Cervical Cancer
